Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells

Pediatric Blood and Cancer

Volumn 48, Issue 4, 2007, Pages 387-392

  Kivivuori, Sanna Maria ^a,b   Siitonen, Sanna ^c   Porkka, Kimmo ^c   Vettenranta, Kim ^b   Alitalo, Riitta ^c   Saarinen Pihkala, Ulla ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiogenesis; Leukemia; Pediatric

Indexed keywords

CD34 ANTIGEN; TIE 1 RECEPTOR; VASCULOTROPIN RECEPTOR 3;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; BONE MARROW; CELL INTERACTION; CELL SURVIVAL; CHILD; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, PRE-B-CELL; MALE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; RECEPTOR, TIE-1; TUMOR STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 33847356496     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20857     Document Type: Article

References (31)

1. Molica S, Vacca A, Levato D, et al. Angiogenesis in acute and chronic lymphocytic leukemia. Leuk Res 2004;28:321-324.
2. Pule MA, Gullmann C, Dennis D, et al. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. Br J Haematol 2002;118:991-998.
3. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240-2245.
4. Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150:815-821.
5. Kubo H, Alitalo K. The bloody fate of endothelial stem cells. Genes Dev 2003;17:322-329.
6. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-583.
7. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001;61:1786-1790.
8. Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000;14:2087-2096.
9. Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-956.
10. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-2412.
11. Oliver G, Detmar M. The rediscovery of the lymphatic system: Old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002;16:773-783.
12. Fielder W, Graeven U, Ergun S, et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 1997;11:1234-1237.
13. Puri MC, Bernstein A. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci USA 2003;100:12753-12758.
14. Armstrong E, Korhonen J, Silvennoinen O, et al. Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 1993;7:1585-1591.
15. Verstovsek S, Estey E, Manshouri T, et al. High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome. Leuk Lymphoma 2001;42:511-516.
16. Jones N, Iljin K, Dumont DJ, Alitalo K. Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2001;2:257-267.
17. Dias S, Choy M, Alitalo K, Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 2002;99:2179-2184.
18. Verstovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer 2002;94:1517-1521.
19. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000;14:2267-2275.
20. Jussila L, Valtola R, Partanen TA, et al. Lymphatic endothelium and Kaposi's sarcome spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998;58:1599-1604.
21. Salven P, Joensuu H, Heikkila P, et al. Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer 1996;74:69-72.
22. Syrjala M, Anttila VJ, Ruutu T, Jansson SE. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Leukemia 1994;8:1564-1570.
23. Campbell MJ. Statistics at square two. Understanding modern statistical applications in medicine. London: BMJ Books; 2001. 133p.
24. Salven P, Mustjoki S, Alitalo R, et al. VEGFR-3 and CD133 identify a population of CD344- lymphatic/vascular endothelial precursor cells. Blood 2003;101:168-172.
25. Larrivee B, Niessen K, Pollet I, et al. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J Immunol 2005;175:2890-2899.
26. Hristov M, Weber C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004;8:498-508.
27. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958.
28. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-1201.
29. Hu Q, Dey AL, Yang Y, et al. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 2004;100:1884-1891.
30. Batard P, Sansilvestri P, Scheinecker C, et al. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 1996;87:2212-2220.
31. Aguayo A, Manshouri T, O'Brien S, et al. Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL). Leuk Res 2001;25:279-285.